Growth charts for patients with Hunter syndrome☆
Children with mucopolysaccharidosis II (MPS II), also known as Hunter syndrome, an X-linked disorder, suffer from a multisystem dysfunction caused by the accumulation of glycosaminoglycans. However, there has been no systemic report on the growth of patients with MPS II. The purpose of this study is...
Main Authors: | Patel, Pravin, Suzuki, Yasuyuki, Maeda, Miho, Yasuda, Eriko, Shimada, Tsutomu, Orii, Kenji E., Orii, Tadao, Tomatsu, Shunji |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060980/ |
Similar Items
-
Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
by: Patel, Pravin, et al.
Published: (2014) -
Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA☆
by: Chinen, Yasutsugu, et al.
Published: (2014) -
Assay for Glycosaminoglycans by Tandem Mass Spectrometry and its Applications
by: Tomatsu, Shunji, et al.
Published: (2014) -
Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: Clinical, biochemical, and pathological improvements
by: Yasuda, Eriko, et al.
Published: (2015) -
Comparison of Liquid Chromatography–Tandem Mass Spectrometry and Sandwich ELISA for Determination of Keratan Sulfate in Plasma and Urine
by: Hintze, Jonathan P., et al.
Published: (2011)